Picture of Silence Therapeutics logo

SLNCF — Silence Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Brief: Silence Therapeutics FY Operating Loss 35.8 Mln Stg

March 30 (Reuters) - Silence Therapeutics PLC  SLN.L :
    * FY REVENUE 5.5 MILLION STG VERSUS 200,000 STG YEAR AGO
    * SILENCE THERAPEUTICS - FY CASH FLOW FROM OPERATING
ACTIVITIES
£10.8M OUTFLOW (2019: £1.7M INFLOW) AGAINST AN OPERATING LOSS OF
£35.8M (2019: £22.7M)

Source text for Eikon:  ID:nRSd9305Ta 
Further company coverage:  SLN.L 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Silence Therapeutics

See all news